Disc Medicine (IRON) Enterprise Value (2020 - 2026)

Disc Medicine (IRON) has 7 years of Enterprise Value data on file, last reported at -$730.2 million in Q1 2026.

• Enterprise Value for Q1 2026 came in at -$730.2 million, down 5.11% year-over-year; the trailing twelve-month figure through Mar 2026 was -$730.2 million (down 5.11% YoY), and the FY2025 annual result was -$791.2 million, down 61.5% from the prior year.
• Enterprise Value climbed to -$730.2 million in Q1 2026 per IRON's latest filing, from -$791.2 million in the prior quarter.
• Over five years, Enterprise Value peaked at -$101.7 million in Q3 2022 and troughed at -$791.2 million in Q4 2025.
• A 5-year average of -$421.9 million and a median of -$377.6 million in 2023 frame the typical range for Enterprise Value.
• The sharpest annual moves came in 2022 and 2023: Enterprise Value soared 35.14% in 2022, then tumbled 264.31% in 2023.
• A 5-year view of Enterprise Value shows it stood at -$194.6 million in 2022, then plunged by 85.18% to -$360.4 million in 2023, then tumbled by 35.93% to -$489.9 million in 2024, then sank by 61.5% to -$791.2 million in 2025, then rose by 7.71% to -$730.2 million in 2026.
• Business Quant data shows IRON's Enterprise Value at -$730.2 million in Q1 2026, -$791.2 million in Q4 2025, and -$615.9 million in Q3 2025.